R2 Technology, Inc. Launches Version 8.1 Mammography CAD System For Maximum Flexibility And Detection Performance

SUNNYVALE, Calif., Nov. 21 /PRNewswire/ -- R2 Technology, Inc., the leader in computer aided detection (CAD) technology for the earlier detection of breast cancer and other medical conditions, today introduced its new ImageChecker(R) Version 8.1 Mammography CAD system. V8.1 is the first CAD solution to offer separate operating points -- between the system's highest sensitivity and lowest false marker rates -- for masses and microcalcifications, providing physicians with maximum flexibility and detection performance. The new release now powers R2's entire mammography CAD processing product line and is available as an upgrade for existing systems. V8.1 will be featured at the 91st Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, November 27 - December 2, in Booth #8532 (North Hall).

"Version 8.1 gives radiologists maximum CAD flexibility when reviewing mammography images," said Shawl Lobree, R2's vice president of marketing. "For example, a site can choose to set the highest sensitivity for microcalcifications, while setting the operating point for masses to a lower false marker rate. This new offering continues our tradition of developing innovative CAD solutions that best meet our customers' clinical and workflow needs." Mr. Lobree noted that R2's installed base, going back to initial ImageChecker mammography CAD systems purchased in 2000, can upgrade to the company's newest Gold Standard CAD(TM) algorithm, flexible operating points and other unique capabilities.

Version 8.1 also contains other exclusive R2 features, including the R2 Malc(TM) mark, which indicates a mass with microcalcifications; EmphaSize(TM) variable size CAD marks, which correlate to lesion significance; and the GreenLight(TM) user interface, which enables technologists to process mammography cases quickly and monitor film scanning from a distance, without interrupting other work.

Five independent prospective clinical studies* from academic and community practices showed that the use of R2's mammography CAD resulted in 6.6 percent to 19.5 percent more cancers detected. Independent studies* comparing CAD performance on architectural distortions, cases graded by difficulty, and small invasive breast cancers all demonstrate the advantage of R2's market-leading CAD algorithm.

R2's Other Featured Products at RSNA Will Include:

DigitalNow(TM) Software System -- This system helps facilitate mammography centers' transition to a digital mammography environment by enabling mammography films to be digitized and archived via DICOM to a PACS for use later in a soft-copy viewing environment.

ImageChecker(R) DMax CAD System -- With its high-throughput and superior laser scanning image quality, this system primarily serves the CAD needs of high-volume mammography centers.

ImageChecker(R) LS CAD System -- This system features R2's Gold Standard CAD(TM) technology in a unique tabletop package and is designed exclusively for low volume, film-based mammography sites.

ImageChecker(R) D CAD System -- Designed exclusively for digital-based mammography centers, this system accepts images from a broad range of digital mammography vendors and delivers CAD results to DICOM workstations or PACS, allowing for maximum flexibility -- even in multi-vendor digital mammography environments.

ImageChecker(R) CT Lung Nodule V2.0 CAD System -- With its AutoPoint(TM) automatic temporal comparison feature, this second-generation, FDA-approved (PMA) system assists in the review of multi-slice CT (MSCT) chest exams to help maximize physician accuracy and efficiency in finding overlooked actionable lung nodules and tracking changes in size over time.

Pulmonary Artery Patency Exam (PE(TM)) for Chest MSCT -- A feature with the ImageChecker CT Lung CAD V2.0, this tool uses CAD technology to help physicians more accurately and efficiently detect potential intravascular pulmonary artery filling defects, such as pulmonary emboli, during review of MSCT exams. Launched in mid-2005, it is the first commercially available tool of its kind.

About R2 Technology, Inc.

R2 Technology, Inc., headquartered in Sunnyvale, CA, is the recognized leader in the development and commercialization of computer aided detection (CAD), an innovative technology that assists physicians in the earlier detection of breast cancer, actionable lung nodules and other lung abnormalities. As a medical imaging company dedicated to diagnostic decision support, increasing physician productivity and preventing medical errors, R2 Technology is developing CAD systems for a variety of imaging modalities and disease states. For more information, visit www.r2tech.com or call 866-243-2533.

ImageChecker is a registered trademark of R2 Technology, Inc.

* Studies available upon request.

R2 Technology, Inc.

CONTACT: Tracy Morris, +1-650-473-1272, or tracy@morrismarcom.com, for R2Technology, Inc.

Back to news